| Name | Title | Contact Details |
|---|
Preferred Commerce, Inc. (OCBM) is the supplier and provider of Elev8, products that contain some of the world`s most powerful antioxidants and cell reparation enzymes such as SOD (Superoxide Dismutase) mononucleotides and other key ingredients that promote healthier cell activity in all living things. SOD is an enzyme that alternately catalyzes the dismutation (or partitioning) of the superoxide (O2-) radical into either ordinary molecular oxygen (O2) or hydrogen peroxide (H2O2). Hydrogen peroxide is also damaging and is degraded by other enzymes such as catalase. Preferred Commerce`s specially formulated Elev8 products have been shown to provide relief to people who have Rheumatoid Arthritis, visible signs of skin damage, Scleroderma, Cataracts, Gout, inflammation, Interstitial Cystitis, Osteoarthritis, Parkinson`s Disease, Alzheimer`s disease, and ADHD, not to mention providing a stimulus for overall healthier lifestyles, cardiovascular health, and mental capacity and focus to people without any known health issues. Preferred Commerce has long been a solution provider to the horticulture and agriculture industries, as well as to consumers. In addition, the company has created training and educational products that have fueled billions of dollars in sales for Fortune 500 companies, while its family-friendly how-to-grow products have educated nearly 1 million children on how to successfully grow their own healthy food at home. As today`s health concerns are escalating, Preferred Commerce feels that Elev8 can play an important part in providing people with healthier lifestyles.
First aid for when fun wins.
Saint Louis Effort for Aids is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Neuralstem is a dual platform regenerative medicine company. The company`s technology enables the production of regionally specific, physiologically relevant neural stem cells for therapeutic use for the treatment of central nervous system (CNS) diseases and has enabled the discovery of a library of patented small molecule neurogenic compounds to treat psychological and cognitive disorders. Neuralstem`s small molecule drug discovery program screens human neural stem cell lines for compounds that may stimulate neurogenesis in the brain, possibly reversing pathologies associated with certain CNS conditions. The company`s lead compound, NSI-189, has completed FDA Phase Ia and Ib safety trials for the treatment of major depressive disorder (MDD). Neuralstem is expecting to launch a Phase II study for MDD in 2015. Neuralstem`s first stem cell therapy product, NSI-566, a spinal cord-derived neural stem cell line, is in ongoing clinical trials to treat amyotrophic lateral sclerosis (ALS, or Lou Gehrig`s disease), for which it has received orphan status designation by the FDA. Dosing in a phase IIa trial was completed in July, 2014. The next trial is anticipated to commence in 2015. In addition to ALS, the company is conducting an NSI-566 Phase I trial in chronic spinal cord injury, with NSI-566 clinical development also underway to treat ischemic
Sand Lake Medical Assoc is a Orlando, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.